Johnson & Johnson to `Grow Above Market' in 2020, CFO Says

The transcript discusses the company's earnings and growth projections for 2019 and 2020, highlighting the impact of the Affordable Care Act on medical devices. It addresses litigation risks, capital allocation plans, and strategies to boost investor confidence. The company aims to grow above market expectations, focusing on pharmaceuticals, medical devices, and consumer health. Despite litigation challenges, the company has completed a $5 billion buyback and plans to increase dividends and make value-creating acquisitions.

What strategies are being implemented to improve profitability in the consumer health sector?

In what ways has the company responded to investor concerns regarding litigation overhang?